| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/18/2004 | CN1475501A New type human bone marrow substrate cell source 1 type phosphoric acid enzyme inhibition factor, its coded sequence and use |
| 02/18/2004 | CN1475500A New type human marrow differentiation tagged object its coded sequence and use |
| 02/18/2004 | CN1475499A New type human cell signal related protein, its code sequence and use |
| 02/18/2004 | CN1475497A Transcription factor for regulating and controlling dry land cotton anti contrary property and its coded gene and application |
| 02/18/2004 | CN1475496A Soybean ethylene response protein transcription factor and its coded gene and application |
| 02/18/2004 | CN1475495A Ethylene response conjugated protein transcription factor of ice plant and its coded gene and application |
| 02/18/2004 | CN1475277A Method of gauze window type rectifying accelerating gene microsphere and gene gun |
| 02/18/2004 | CN1138860C Ribosome S6 protein kinase |
| 02/18/2004 | CN1138859C Infection clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 02/18/2004 | CN1138858C Nuclear-encoded transcription system in plastids of higher plants |
| 02/18/2004 | CN1138857C Zymolase of agricultural chemical containing organic phosphorus and its coding gene and preparing process |
| 02/18/2004 | CN1138856C Engineering bacteria for epidermal growth factor and preparation of epidermal growth factor by using this bacteria |
| 02/18/2004 | CN1138786C Antibody for identifying osteoclast forming inhibitor binding protein, and preparing process and use |
| 02/18/2004 | CN1138563C Vector for diagnosis and treatment of solid tumors including melanoma |
| 02/18/2004 | CN1138562C Use of muteins of wild-type cytokines as immunogens |
| 02/18/2004 | CN1138533C Liposomes |
| 02/17/2004 | WO2004076645A3 Compositions and methods for cytomegalovirus treatment |
| 02/17/2004 | US6693228 Alteration of flowering time in plants |
| 02/17/2004 | US6693227 Inducibile plant promoters |
| 02/17/2004 | US6693226 First model for tau pathology in alzheimer's disease |
| 02/17/2004 | US6693186 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
| 02/17/2004 | US6693185 Genetic engineering |
| 02/17/2004 | US6693183 MURINE α (1,3) FUCOSYLTRANSFERASE FUC-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 02/17/2004 | US6693182 Mammalian galanin receptors |
| 02/17/2004 | US6693181 Protein secretion |
| 02/17/2004 | US6693174 Nucleotide sequences coding fungicide for use in the prevention of fungal infections |
| 02/17/2004 | US6693171 ACPL polypeptides |
| 02/17/2004 | US6693167 Peptide-based gemini compounds |
| 02/17/2004 | US6693081 Bone stimulating factor |
| 02/17/2004 | US6693079 Insulin-like growth factor agonist molecules |
| 02/17/2004 | US6693078 Insulin-like growth factor agonist molecules |
| 02/17/2004 | US6693075 Factor viia polypeptide comprising modified carboxyglutamic acid domain; enhancing membrane binding affinity and activity |
| 02/17/2004 | US6692966 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 02/17/2004 | US6692965 Exposing to molecular beacon comprised of nucleotides complementary to rna of interest; isolating cells that fluoresce upon hybridization |
| 02/17/2004 | US6692964 Stimulating proliferating cell prior to introducing nucleic acid molecule |
| 02/17/2004 | US6692962 Construct for knocking out eif2 alpha gene |
| 02/17/2004 | US6692960 Gene expression inhibition; treating developmental disorders or aberrant apoptosis |
| 02/17/2004 | US6692959 Hybrid nucleic acids; prevent, controlling gene expression; antiinflammatory agents |
| 02/17/2004 | US6692956 Recombinant adenoviral vectors |
| 02/17/2004 | US6692955 HIV vaccine |
| 02/17/2004 | US6692954 Generation of human cytomegalovirus yeast artificial chromosome recombinants |
| 02/17/2004 | US6692951 Protein particle for use as genetic engineering tool in expression of heterologous proteins in bacillus |
| 02/17/2004 | US6692950 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid |
| 02/17/2004 | US6692947 Structural similarity with animal beta 1,4 n-acetylgalac-tosamine transferases |
| 02/17/2004 | US6692945 Expression vector for use in the generation of preferential compounds |
| 02/17/2004 | US6692943 Persephin and related growth factors |
| 02/17/2004 | US6692942 Single-chain polypeptides for targeted delivery of nucleic acids |
| 02/17/2004 | US6692941 Bovine growth hormone |
| 02/17/2004 | US6692940 Utilizing nucleotides 1 to 3060 of sequence number 3 or subsequence thereof |
| 02/17/2004 | US6692939 Nucleotide sequences encoding mammalian calcium activated chloride channel-adhesion molecules |
| 02/17/2004 | US6692938 Peptide for use in the treatment of inflammation, arthritis, glomerulonephritis, asthma, psoriasis, viral infections, cancer, atherosclerosis, leukemia and autoimmune diseases |
| 02/17/2004 | US6692937 Nucleotide sequences coding membrane protein for use in the treatment of cancer, infection and heart defects |
| 02/17/2004 | US6692936 Novel polypeptide belonging to the class of proteins known as g-protein coupled receptors |
| 02/17/2004 | US6692935 Fusion of peptide or protein association domains designed to assemble in a complementary fashion, thereby providing multifunctional (poly)peptides |
| 02/17/2004 | US6692932 Thermostable DNA polymerase from anaerocellum thermophilum |
| 02/17/2004 | US6692929 Polypeptide; for use in detection of cell cycle modulators |
| 02/17/2004 | US6692924 Methods of using cytokine receptor zalpha11 to detect its ligands |
| 02/17/2004 | US6692911 Cell delivery compositions |
| 02/17/2004 | US6692910 Controlling, reducing gene expression; genetic engineering; viricides; anticancer agents; genetic disorders |
| 02/17/2004 | US6692908 Prevention and treatment of HCV infection employing antibodies that inhibit the interaction of HCV virions with their receptor |
| 02/17/2004 | US6692907 Conserved motif of hepatitis C virus E2/NS1 region |
| 02/17/2004 | US6692750 Introducing into cells recombinant alphavirus rna genome and helper rna encoding alphavirus structural proteins, including coding sequences for proteins and cis acting replication signals; incubating to produce infectious virus particles |
| 02/17/2004 | US6692748 Adipocyte complement related protein zacrp3x2 and nucleic acids encoding zacrp3x2 |
| 02/17/2004 | US6692747 Peptide for use in the treatment of infections, viral and cancer diseases |
| 02/17/2004 | US6692744 Betaglycan as an inhibin receptor and uses thereof |
| 02/17/2004 | US6692742 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 02/17/2004 | US6692741 Treatment of acute lung injury and fibrosis with antagonists of β6-specific antibodies |
| 02/17/2004 | US6692740 Nucleotide sequences coding polypeptide for use in the treatment of arthritis, osteoporosis, liver, diabetic and inflammatory bowel diseases |
| 02/17/2004 | US6692737 In vivo protein production and delivery system for gene therapy |
| 02/17/2004 | US6692736 Replication-competent adenovirus vector including two genes co-transcribed as single mrna under transcriptional control of heterologous target cell-specific transcriptional regulatory element; one has mutation or deletion of endogenous promoter |
| 02/17/2004 | US6692735 Truncated variant of c6 beta-chemokine leukotactin-1 polypeptide consisting of specified amino acid sequence |
| 02/17/2004 | US6692703 Washing solution is fed into a tip containing the solid phase unidirectionally from head to end |
| 02/17/2004 | US6691457 Floral packaging material having great masters prints thereon |
| 02/17/2004 | CA2143325C Cloning and expression of .beta.app-c100 receptor |
| 02/17/2004 | CA2112667C Monoclonal antibodies to putative hcv ns5 proteins and methods for using same |
| 02/16/2004 | CA2437478A1 Brassica pdhk gene |
| 02/12/2004 | WO2004014112A2 Apparatus and method for fabricating, sorting, and integrating materials with holographic optical traps |
| 02/12/2004 | WO2004013629A2 Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
| 02/12/2004 | WO2004013620A1 Fluorescence correlation spectroscopy instrument |
| 02/12/2004 | WO2004013610A2 Method of measuring molecular interactions |
| 02/12/2004 | WO2004013355A1 Sirna-mediated gene silencing with viral vectors |
| 02/12/2004 | WO2004013353A1 Analysis of biological samples |
| 02/12/2004 | WO2004013351A2 Target dna |
| 02/12/2004 | WO2004013350A1 Methods for rolling circle amplification and signal trapping of libraries |
| 02/12/2004 | WO2004013336A2 Use of pox4 promoter to increase gene expression in candida tropicalis |
| 02/12/2004 | WO2004013335A1 Herbicide screening target |
| 02/12/2004 | WO2004013334A1 Clubroot resistant brassica oleracea plants |
| 02/12/2004 | WO2004013333A2 Inversion of the negative-selective effect of negative marker proteins using selection methods |
| 02/12/2004 | WO2004013332A1 Substrate conversion |
| 02/12/2004 | WO2004013331A1 Pathogenic genes of xanthomonas oryzae pv. oryzae and utilization thereof |
| 02/12/2004 | WO2004013330A1 Multifunctional genetic constructions having a high capacity to inhibit the expression of ccr5 on the cell surface |
| 02/12/2004 | WO2004013329A1 Dna extraction microchip, system and method |
| 02/12/2004 | WO2004013328A1 Method for generating molecules with specific properties by recombination and selection |
| 02/12/2004 | WO2004013327A1 Method for the expression of unknown environmental dna into adapted host cells |
| 02/12/2004 | WO2004013323A1 Sequence of a putative humain serine protease |
| 02/12/2004 | WO2004013321A1 Esterase esta (xc4a) of xanthomonas vesicatoria |
| 02/12/2004 | WO2004013319A2 Regulation of human esterase |
| 02/12/2004 | WO2004013313A2 Antisense nucleic acids |
| 02/12/2004 | WO2004013312A2 Tocopherol biosynthesis related genes and uses thereof |
| 02/12/2004 | WO2004013310A2 Methods of down regulating target gene expression in vivo by introduction of interfering rna |